Dying for Access

It costs on average $802 million to develop a new drug, but not every drug makes it to market. Many are stuck in clinical trials and could take more than a decade to get approved. Critics claim the FDA takes too long to give the go-ahead to life-saving medications and therapies. Others believe it's better to be safe than sorry. Lives hang in the balance of this debate.

• Read Full Report >
• Read Research Summary >
• Read Q&A >

Animal Testing: Progress or Pain?

Each year in the name of medical progress, scientists experiment with 100 million mice, rats, monkeys, fish and dogs. They expose the animals to medicines and therapies that could become the next cancer killer or depression fighter, but are the tests a move forward or backward?

• Read Full Report >
• Read Research Summary >
• Read Q&A >

At Your Own Risk

There are 40,000 clinical trials going on in the United States right now and more than a million people are taking part in them. That's more people than in the state of Alaska. All participants hope for a breakthrough that will save their life and the lives of others, but is the risk worth it? Ivanhoe reports on the good, the bad and the unknown of clinical trials.

• Read Full Report >
• Read  Research Summary >
• Read Q&A >

If a treatment you read about here helps you, let us know...click here.